How Psychometrics Influence PRO Selection for Clinical Trials
🔍 In this whitepaper, you’ll find detailed insights on:
- The importance of psychometrics in selecting Patient-Reported Outcomes (PROs) for clinical trials
- Key psychometric properties, such as validity, reliability, responsiveness, and floor/ceiling effects, and their impact on data quality
- The regulatory landscape and expectations regarding PRO data from bodies like the FDA, EMA, and MHRA
💡 Why download our whitepaper?
- Understand how psychometrics can improve data accuracy and regulatory success
- Learn how to select robust PRO instruments to generate high-quality real-world data
- Discover strategies to avoid common pitfalls in PRO application that can lead to failed submissions or increased study costs
Don’t miss this essential guide! Click the link below to download and optimize the use of PROs in your clinical research.
